HYALTECH LTD.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +32.7%

  £10,242,423 → £13,590,528

  highest in 4 filed years

• Cash

  +1,272.9%

  £37,925 → £520,673

  highest in 4 filed years

• Net assets

  -176%

  -£2,968,179 → -£8,193,261

  lowest in 4 filed years

• Employees

  +12.3%

  73 → 82

  highest in 4 filed years

• Operating profit

  +25.4%

  -£5,695,403 → -£4,247,579

• Profit before tax

  +16.6%

  -£6,267,488 → -£5,225,083

• Wages

  +14.4%

  £3,177,714 → £3,635,249

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. HYALTECH LTD. 2002-08-15 → present
2. LOTHIAN FIFTY (841) LIMITED 2001-09-05 → 2002-08-15

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“To support the company as a Going Concern, Carl Zeiss AG has confirmed that it will provide such financial support and other support as necessary to enable the company to meet its liabilities for at least the next 12 months from the date the accounts have been signed. As set out in note 22, Carl Zeiss AG is the ultimate parent Company and controlling party incorporated in Germany and is the largest group in which results of the Company are consolidated. The directors have a reasonable expectation that the Carl Zeiss Group has adequate resources and liquidity to continue in operational existence for the review period. Accordingly, the directors consider it apppropriate to adopt the going concern basis in preparing these financial statements.”

Significant events

• “The ophthalmic sector has increased revenues of 14% on prior year and the orthopaedic sector has decreased revenues of 10% on prior year. This was a management decision to focus capacity on opthalmic products in the year. The losses in 2024 have been primarily caused by reduced volume whilst continuing to invest in strengthening the company's supply chain and scrapping of work in progress due to batch failures. The cause of these batch failures has now been addressed through production process improvements and improvements in procurement processes. The company will continue to deliver revenues from existing products through its partner companies, improve production capacity and reliability as well as trying to bring new products through to the market. The budgeted demand for product in FY25 is high and was evident in Q1 FY25. Over the course of the year the company expects to return to a profit making position.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.